Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Biomemory logo — Biomemory provides biodigital data storage for large compani...

Biomemory

Biomemory provides biodigital data storage for large companies and administrations.

Founded 2021 France France 84 employees Series A Total: $23.00M Biotechnology, Data Analytics

General Information

Company Name Biomemory
Founded Year 2021
Location France France +1
Employees 84
Industries Biotechnology, Data Analytics
Funding Stage Series A
Social

Get notified when Biomemory moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Raising Funds Sep 07, 2026

Biomemory is seeking long-term capital and committed partners to finance its growth and bring its DNA-based data storage ambition to industrial scale.

Event Participation Sep 07, 2026

Biomemory is participating in the France-Korea Deeptech Investment Summit in Paris, where its CEO, Laurent Guengant, will present the company.

Award Received Sep 07, 2026

Biomemory was recognized, ranking #31 in TechRound's US50 2026 list for its DNA data storage work.

Program Acceptance Aug 19, 2026

Biomemory has participated in the Creative Destruction Lab program, specifically its Climate and Next Generation Computing streams.

Homepage Update

Significant changes detected on company website (84.4% content change).

Actively Hiring Aug 12, 2026

Hiring for 1 position in the last 30 days.

Get alerts when Biomemory shows new signals

AI Insight

Bounce Watch AI
3 weeks ago

Biomemory is actively solidifying its market position and deep-tech leadership, evidenced by a senior executive presenting on DNA data storage standards at a major industry conference in July 2026. This strategic engagement, alongside recent hiring and a significant website refresh, suggests the company is preparing for further commercial expansion and product maturation following its Series A funding.

Signal Types
Industry Engagement Hiring Product Update
Strategic Labels
Industry Leadership Market Positioning Operational Scaling
Next Move: Expansion
·
Impact: 8/10
·
Ideal For: Deep-Tech & Enterprise Storage Investors — Growth Stage

About Biomemory

Biomemory is a pioneering biotechnology and data analytics company based in France, established in 2021. The company's core innovation lies in its biodigital data storage solutions tailored to large enterprises and governmental administrations. Through advanced molecular engineering, Biomemory creates exabyte rackable appliances that offer both cost-effectiveness and energy efficiency for Data Centers.

Apart from data storage, Biomemory is innovating in DNA-based anti-counterfeiting systems, aligning with sustainability by maintaining a minimal ecological footprint. This dual focus on data storage and security positions the company uniquely in the market.

In its latest funding round, Biomemory secured a $18.00M Series A investment on 01 December 2024, with backing from notable investors such as Bpifrance, Crédit Mutuel Innovation, and Paris Business Angels. This substantial investment underscores investor confidence in Biomemory's technology and its potential for broad market impact.

Taxonomy: Biodigital Data Storage, Enterprise Data Storage, Molecular Engineering, Data Center Solutions, Cost-effective Solutions, Energy-efficient Solutions, Exabyte-scale Appliances, DNA Data Storage, Molecular Storage, Molecular Computing, Anti-counterfeiting Systems, Ecological Impact Minimization, Deep-tech

Services & Products

DNA Data Storage solutions
Cybersecurity tailored for data centers
IT-friendly DNA storage and biosecure solutions
Long-term data retention and readability support

Target Customers

Data Centers Enterprise-level IT environments Organizations with high-security and data preservation needs Companies seeking scalable, sustainable storage options

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 7
Investor Investor Investor Investor
•••• •••• 		01 Dec 2024
Seed •••••• 3
Investor
•••• •••• 		01 Nov 2022
Support Program •••••• 1
Investor
01 Dec 2021
Support Program •••••• 1
Investor
01 Sep 2021
Spinout •••••• 4
Investor Investor
•••• •••• 		01 Jun 2021

Biomemory Alternatives & Competitors

View All Alternatives
Biomemory vs
Epigenetiks Genetik Biyoinformatik Yazılım A.Ş.
Epigenetiks Genetik Biyoinformatik Yazılım A.Ş. Turkey

Comprehensive bioinformatics solutions tailored to address all challenges.

10 employees
Digital Health, Health Care
Compare Biomemory vs Epigenetiks Genetik Biyoinformatik Yazılım A.Ş.
Biomemory vs
CATALOG
CATALOG United States

DNA Computing Company

Series B
14 employees
Analytics, Biotechnology
Compare Biomemory vs CATALOG
Biomemory vs
Cyphergram
Cyphergram Estonia

Secure and privacy compliant customer personal data processing platform for businesses

Pre Seed
1 employees
Blockchain, Cloud Infrastructure
Compare Biomemory vs Cyphergram
View all alternatives

FAQ About Biomemory

Biomemory provides biodigital data storage for large companies and administrations.
Biomemory was founded in 2021.
Biomemory is headquartered in France.
Biomemory operates in the following industries: Biotechnology, Data Analytics.
Biomemory has approximately 84 employees.
Biomemory has completed 5 funding rounds, raising a total of $23.00M. The latest funding stage is Series A.
Biomemory offers: DNA Data Storage solutions, Cybersecurity tailored for data centers, IT-friendly DNA storage and biosecure solutions, Long-term data retention and readability support.
Top alternatives and competitors to Biomemory include Epigenetiks Genetik Biyoinformatik Yazılım A.Ş., CATALOG, Cyphergram, Bitquery , Just a Little Data / Unlock Knowledge. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biomemory and Epigenetiks Genetik Biyoinformatik Yazılım A.Ş. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biomemory and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy